Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brent S Rose

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
BJU International|January 19, 2019
Postoperative radiation and hormonal therapy for men with node-positive prostate cancer: a new standard?Brent S Rose
JAMA Internal Medicine|October 8, 2019
5α-Reductase Inhibitor Use in Patients With Prostate Cancer-ReplyReith R Sarkar, Brent S Rose
JAMA Internal Medicine|October 8, 2019
Benefits of Targeted Use of 5α-Reductase Inhibitors in Patients With Prostate Cancer-ReplyReith R Sarkar, Brent S Rose
International Journal of Radiation Oncology, Biology, Physics|April 11, 2019
In Reply to Hurmuz and OzyigitAlex K Bryant, Brent S Rose
Cancer|July 10, 2020
Reply to Equal access to health care reduces racial disparities in prostate cancer outcomes and Access and socioeconomic status play an important role in outcomes for African American patients with prostate cancerPaul J Riviere, Brent S Rose
Breast Cancer Research and Treatment|June 5, 2015
Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancerBrent S Rose, Wei Jiang, Rinaa S Punglia
JAMA Oncology|November 20, 2018
Detecting a Survival Benefit to Dose EscalationKaveh Zakeri, Brent S Rose, Loren K Mell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2014
On lumping, splitting, and the nosology of clinical trial populations and end pointsLoren K Mell, Kaveh Zakeri, Brent S Rose
Translational Andrology and Urology|April 13, 2018
Who benefits most from early salvage radiation therapy after prostatectomy?Sameer K Nath, Brent S Rose, Thomas J Pugh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2017
Reply to S. SorscherBrent S Rose, Eric P Winer, Harvey J Mamon
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
BJU International|January 19, 2019
Postoperative radiation and hormonal therapy for men with node-positive prostate cancer: a new standard?Brent S Rose
JAMA Internal Medicine|October 8, 2019
5α-Reductase Inhibitor Use in Patients With Prostate Cancer-ReplyReith R Sarkar, Brent S Rose
JAMA Internal Medicine|October 8, 2019
Benefits of Targeted Use of 5α-Reductase Inhibitors in Patients With Prostate Cancer-ReplyReith R Sarkar, Brent S Rose
International Journal of Radiation Oncology, Biology, Physics|April 11, 2019
In Reply to Hurmuz and OzyigitAlex K Bryant, Brent S Rose
Cancer|July 10, 2020
Reply to Equal access to health care reduces racial disparities in prostate cancer outcomes and Access and socioeconomic status play an important role in outcomes for African American patients with prostate cancerPaul J Riviere, Brent S Rose
Breast Cancer Research and Treatment|June 5, 2015
Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancerBrent S Rose, Wei Jiang, Rinaa S Punglia
JAMA Oncology|November 20, 2018
Detecting a Survival Benefit to Dose EscalationKaveh Zakeri, Brent S Rose, Loren K Mell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2014
On lumping, splitting, and the nosology of clinical trial populations and end pointsLoren K Mell, Kaveh Zakeri, Brent S Rose
Translational Andrology and Urology|April 13, 2018
Who benefits most from early salvage radiation therapy after prostatectomy?Sameer K Nath, Brent S Rose, Thomas J Pugh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2017
Reply to S. SorscherBrent S Rose, Eric P Winer, Harvey J Mamon
Pageof 14